• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丹麦 2003-2010 年新发心力衰竭患者的护理质量趋势:一项全国性队列研究。

Trends in quality of care among patients with incident heart failure in Denmark 2003-2010: a nationwide cohort study.

机构信息

Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.

出版信息

BMC Health Serv Res. 2013 Oct 5;13:391. doi: 10.1186/1472-6963-13-391.

DOI:10.1186/1472-6963-13-391
PMID:24093516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3851278/
Abstract

BACKGROUND

The treatment of heart failure (HF) is complex and the prognosis remains serious. A range of strategies is used across health care systems to improve the quality of care for HF patients. We present results from a nationwide multidisciplinary initiative to monitor and improve the quality of care and clinical outcome of HF patients using indicator monitoring combined with systematic auditing.

METHODS

We conducted a nationwide, population-based prospective study using data from the Danish Heart Failure Registry. The registry systematically monitors and audits the use of guideline recommended processes of care at Danish hospital departments treating incident HF patients. We identified patients registered between 2003 and 2010 (n = 24,504) and examined changes in use of recommended processes of care and 1-year mortality.

RESULTS

The use of the majority of the recommended processes of care increased substantially from 2003 to 2010: echocardiography (from 62.7% to 90.5%; Relative Risk (RR) 1.45 (95% CI, 1.39-1.50)), New York Heart Association classification (from 29.4% to 85.5%; RR 2.91 (95% CI, 2.69-3.14)), betablockers (from 72.6% to 88.3%; RR 1.23 (95% CI, 1.15-1.29)), physical training (from 5.6% to 22.8%; RR 4.04 (95% CI, 2.96-4.52)), and patient education (from 49.3% to 81.4%; RR 1.65 (95% CI, 1.52-1.80)). Use of ACE/ATII inhibitors remained stable (from 92.0% to 93.2%; RR 1.01 (95% CI, 0.99-1.04)). During the same period, 1-year mortality dropped from 20.5% to 12.8% (adjusted Hazard Ratio 0.79 (95% CI, 0.65-0.96).

CONCLUSIONS

Use of guideline recommended processes of care has improved among patients with incident HF included in the Danish Heart Failure Registry between 2003 and 2010. During the same period, a decrease in mortality was observed.

摘要

背景

心力衰竭(HF)的治疗较为复杂,预后仍然较为严重。各医疗体系采用了一系列策略来提高 HF 患者的护理质量。我们报告了一项全国性多学科倡议的结果,该倡议使用指标监测和系统审核来监测和改善 HF 患者的护理质量和临床结局。

方法

我们进行了一项全国性、基于人群的前瞻性研究,使用丹麦心力衰竭登记处的数据。该登记处系统地监测和审核丹麦医院科室治疗新发 HF 患者时指南推荐的护理流程的使用情况。我们确定了 2003 年至 2010 年期间登记的患者(n=24504),并检查了推荐的护理流程使用情况和 1 年死亡率的变化。

结果

从 2003 年到 2010 年,大多数推荐的护理流程的使用大幅增加:超声心动图(从 62.7%增加到 90.5%;相对风险(RR)1.45(95%可信区间,1.39-1.50)),纽约心脏协会分类(从 29.4%增加到 85.5%;RR 2.91(95%可信区间,2.69-3.14)),β受体阻滞剂(从 72.6%增加到 88.3%;RR 1.23(95%可信区间,1.15-1.29)),体力训练(从 5.6%增加到 22.8%;RR 4.04(95%可信区间,2.96-4.52))和患者教育(从 49.3%增加到 81.4%;RR 1.65(95%可信区间,1.52-1.80))。ACE/ATII 抑制剂的使用保持稳定(从 92.0%增加到 93.2%;RR 1.01(95%可信区间,0.99-1.04))。在此期间,1 年死亡率从 20.5%下降到 12.8%(调整后的风险比 0.79(95%可信区间,0.65-0.96))。

结论

在 2003 年至 2010 年期间,丹麦心力衰竭登记处登记的新发 HF 患者中,指南推荐的护理流程的使用有所改善。在此期间,死亡率有所下降。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49f/3851278/1d21b5e965d3/1472-6963-13-391-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49f/3851278/770399de76fa/1472-6963-13-391-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49f/3851278/1d21b5e965d3/1472-6963-13-391-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49f/3851278/770399de76fa/1472-6963-13-391-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49f/3851278/1d21b5e965d3/1472-6963-13-391-2.jpg

相似文献

1
Trends in quality of care among patients with incident heart failure in Denmark 2003-2010: a nationwide cohort study.丹麦 2003-2010 年新发心力衰竭患者的护理质量趋势:一项全国性队列研究。
BMC Health Serv Res. 2013 Oct 5;13:391. doi: 10.1186/1472-6963-13-391.
2
Age- and sex-related differences in use of guideline-recommended care and mortality among patients with incident heart failure in Denmark.丹麦初发心力衰竭患者在使用指南推荐治疗及死亡率方面的年龄和性别差异。
Age Ageing. 2016 Sep;45(5):635-42. doi: 10.1093/ageing/afw119. Epub 2016 Jul 18.
3
Association between process performance measures and 1-year mortality among patients with incident heart failure: a Danish nationwide study.丹麦全国范围内研究:事件性心力衰竭患者的过程绩效指标与 1 年死亡率之间的关联。
Eur Heart J Qual Care Clin Outcomes. 2019 Jan 1;5(1):28-34. doi: 10.1093/ehjqcco/qcy041.
4
Quality of Care and Outcomes of Heart Failure Among Patients With Schizophrenia in Denmark.丹麦精神分裂症患者的心力衰竭护理质量与治疗结果
Am J Cardiol. 2017 Sep 15;120(6):980-985. doi: 10.1016/j.amjcard.2017.06.027. Epub 2017 Jun 27.
5
Inequalities in heart failure care in a tax-financed universal healthcare system: a nationwide population-based cohort study.税收资助的全民医疗保健系统中心力衰竭护理的不平等:一项基于全国人口的队列研究。
ESC Heart Fail. 2020 Oct;7(5):3095-3108. doi: 10.1002/ehf2.12938. Epub 2020 Aug 7.
6
Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure.与因心力衰竭入院患者的医院容量、护理过程和结局之间的关联:来自 Get With The Guidelines-Heart Failure 的见解。
Circulation. 2018 Apr 17;137(16):1661-1670. doi: 10.1161/CIRCULATIONAHA.117.028077. Epub 2018 Jan 29.
7
Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.基于证据的心力衰竭药物治疗的处方模式和 ASIAN-HF 注册研究的结果:一项队列研究。
Lancet Glob Health. 2018 Sep;6(9):e1008-e1018. doi: 10.1016/S2214-109X(18)30306-1.
8
Association between enrolment in a heart failure quality registry and subsequent mortality-a nationwide cohort study.心力衰竭质量登记处登记与随后死亡率的关系:一项全国性队列研究。
Eur J Heart Fail. 2017 Sep;19(9):1107-1116. doi: 10.1002/ejhf.762. Epub 2017 Feb 23.
9
The Danish Heart Failure Registry.丹麦心力衰竭注册中心。
Clin Epidemiol. 2016 Oct 25;8:497-502. doi: 10.2147/CLEP.S99504. eCollection 2016.
10
Improving quality of care among COPD outpatients in Denmark 2008-2011.2008 - 2011年丹麦慢性阻塞性肺疾病门诊患者护理质量的改善
Clin Respir J. 2013 Oct;7(4):319-27. doi: 10.1111/crj.12009. Epub 2013 Jan 22.

引用本文的文献

1
Healthcare performance for patients with heart failure in Iran: addressing the tip of the iceberg.伊朗心力衰竭患者的医疗保健表现:冰山一角。
BMC Health Serv Res. 2024 Oct 30;24(1):1317. doi: 10.1186/s12913-024-11699-1.
2
Development of the International Cardiac Rehabilitation Registry Including Variable Selection and Definition Process.国际心脏康复注册研究的建立,包括变量选择和定义过程。
Glob Heart. 2022 Jan 11;17(1):1. doi: 10.5334/gh.1091. eCollection 2022.
3
Introduction of sacubitril/valsartan in primary care follow-up of heart failure: a prospective observational study (THESEUS).

本文引用的文献

1
Incremental Reduction in Risk of Death Associated With Use of Guideline-Recommended Therapies in Patients With Heart Failure: A Nested Case-Control Analysis of IMPROVE HF.指南推荐疗法的使用与心力衰竭患者死亡风险降低相关:来自 IMPROVE HF 的巢式病例对照分析。
J Am Heart Assoc. 2012 Feb;1(1):16-26. doi: 10.1161/JAHA.111.000018. Epub 2012 Feb 20.
2
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.《2012年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南》:欧洲心脏病学会2012年急性和慢性心力衰竭诊断与治疗特别工作组编著。与欧洲心脏病学会心力衰竭协会(HFA)合作制定。
Eur Heart J. 2012 Jul;33(14):1787-847. doi: 10.1093/eurheartj/ehs104. Epub 2012 May 19.
3
沙库巴曲缬沙坦在心力衰竭初级保健随访中的应用:一项前瞻性观察性研究(忒修斯研究)
ESC Heart Fail. 2020 Aug;7(4):1626-1634. doi: 10.1002/ehf2.12716. Epub 2020 May 5.
4
Incidence and prognosis of heart failure in persons with type 2 diabetes compared with individuals without diabetes - a nation-wide study from Finland in 1996-2012.2012 年芬兰全国范围研究:2 型糖尿病患者与非糖尿病患者心力衰竭发生率和预后比较。
Ann Med. 2019 Mar;51(2):174-181. doi: 10.1080/07853890.2019.1602734. Epub 2019 May 6.
5
Benchmarking Danish hospitals on mortality and readmission rates after cardiovascular admission.丹麦医院心血管疾病入院后死亡率和再入院率的基准评估。
Clin Epidemiol. 2019 Jan 4;11:67-80. doi: 10.2147/CLEP.S189263. eCollection 2019.
6
Burden of heart failure in Flemish general practices: a registry-based study in the Intego database. Flemish 综合诊所心力衰竭负担:Intego 数据库中的基于登记的研究。
BMJ Open. 2019 Jan 7;9(1):e022972. doi: 10.1136/bmjopen-2018-022972.
7
Use of histamine H receptor antagonists and outcomes in patients with heart failure: a nationwide population-based cohort study.组胺H受体拮抗剂的使用与心力衰竭患者的预后:一项基于全国人口的队列研究。
Clin Epidemiol. 2018 May 7;10:521-530. doi: 10.2147/CLEP.S162909. eCollection 2018.
8
The role of the clinical departments for understanding patient heterogeneity in one-year mortality after a diagnosis of heart failure: A multilevel analysis of individual heterogeneity for profiling provider outcomes.临床科室在理解心力衰竭诊断后一年死亡率的患者异质性中的作用:对提供方结局进行个体化异质性分析以建立概况的多水平分析。
PLoS One. 2017 Dec 6;12(12):e0189050. doi: 10.1371/journal.pone.0189050. eCollection 2017.
9
Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation - Results from the German EuroAspire IV cohort.冠心病患者的心力衰竭:患病率、特征及指南实施情况——德国EuroAspire IV队列研究结果
BMC Cardiovasc Disord. 2017 May 5;17(1):108. doi: 10.1186/s12872-017-0543-0.
10
The Danish Heart Failure Registry.丹麦心力衰竭注册中心。
Clin Epidemiol. 2016 Oct 25;8:497-502. doi: 10.2147/CLEP.S99504. eCollection 2016.
Ten years of structural reforms in Danish healthcare.丹麦医疗保健领域的十年结构性改革。
Health Policy. 2012 Jul;106(2):114-9. doi: 10.1016/j.healthpol.2012.03.019. Epub 2012 Apr 21.
4
Get With The Guidelines program participation, process of care, and outcome for Medicare patients hospitalized with heart failure.参与“遵循指南”项目的医疗保险心力衰竭住院患者的治疗过程及结果。
Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):37-43. doi: 10.1161/CIRCOUTCOMES.110.959122. Epub 2012 Jan 10.
5
Improving quality of care and outcomes for heart failure. -Role of registries-.改善心力衰竭的护理质量和结果。-登记处的作用-。
Circ J. 2011;75(8):1783-90. doi: 10.1253/circj.cj-11-0582. Epub 2011 Jul 5.
6
Potential impact of optimal implementation of evidence-based heart failure therapies on mortality.优化实施基于证据的心力衰竭治疗对死亡率的潜在影响。
Am Heart J. 2011 Jun;161(6):1024-30.e3. doi: 10.1016/j.ahj.2011.01.027.
7
Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction.接受基于证据的治疗与 ST 段抬高型心肌梗死患者生存的关联。
JAMA. 2011 Apr 27;305(16):1677-84. doi: 10.1001/jama.2011.522.
8
Epidemiology and risk profile of heart failure.心力衰竭的流行病学和风险特征。
Nat Rev Cardiol. 2011 Jan;8(1):30-41. doi: 10.1038/nrcardio.2010.165. Epub 2010 Nov 9.
9
Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).改善门诊心脏病学实践中心力衰竭的循证护理:改善门诊心力衰竭证据治疗应用注册研究(IMPROVE HF)的主要结果。
Circulation. 2010 Aug 10;122(6):585-96. doi: 10.1161/CIRCULATIONAHA.109.934471. Epub 2010 Jul 26.
10
Evidence-based heart failure performance measures and clinical outcomes: a systematic review.基于证据的心力衰竭绩效指标与临床结局:一项系统评价。
J Card Fail. 2010 May;16(5):411-8. doi: 10.1016/j.cardfail.2010.01.005. Epub 2010 Mar 3.